Fig. 1From: Risk factors for thromboembolism during first-line treatment of patients with unresectable advanced or recurrent colorectal cancer: a retrospective short studyComparison of thromboembolism incidence between molecular-targeted therapies. Fisher's exact probability test was used for all analyses. The horizontal axis shows the rate of eventsBack to article page